Diagnosis, Prognosis and Therapeutic Targeting

Dr. Bismar is currently a Professor at the University of Calgary and Adjunct Professor in the Department of Oncology at McGill University. For this talk he gives us an update on the innovations and processes used to diagnose, treat and target prostate cancer cells using the most acronyms you’re likely ever to see. A lively debate follows in the Q&A section about the worth and value of PSA testing and more.

Studies in Metastases: Or How Chickens Help Fight Prostate Cancer

Desmond Pink, Ph.D. is the Chief Science Officer at Nanostics Inc. and as a Research Associate at the Dr. John Lewis Laboratory of oncology at the University of Alberta, him and his team are doing sophisticated testings to study just how cancer spreads. Studying chicken embryos can tell us about the development and metastasis of tumor growth and how we can image it and potentially we can fight it.

Recent Advances in Prostate Cancer Treatment

Prostaid Calgary Director Saif Lalani looks at today’s changing landscape for prostate cancer treatment with a deeper look at the following treatments: Darolutamide, Xofigo/Radium 223, and Prostate Specific Membrane Antigen (PSMA), their qualities and their availability today in Canada and beyond.

Patient Reported Outcomes

Dr. Linda Watson, the Scientific Director of Applied Research for Alberta Health Services speaks on Integrating Patient Reported Outcomes (PRO’s) into Ambulatory Care Processes in Cancer Control Alberta (CCA). She talks about the reality of health care in Alberta, how to get better outcomes for patients and how PRO tools can help us all advance the way we do health care.

Prostate Images: An Update with Mayfair Diagnostics

Shelley Spaner, Grace Yeung, Brendan Diederichs from Mayfair Diagnostics join PROSTAID Calgary this month for an update on where prostate imaging is in 2019 and how far it has come in the last 3 years. Brendan updates the audience on the Brand New 3Tesla Magnet at the Rockyview General Hospital and talks about its new features. Grace reviews the targeted biopsy program and Shelley reviews the updated literature on Imaging in Active Surveillance and patients in treatment. A detailed Q & A follows.

Gary Bobrovitz on his Journey with Prostate Cancer

Celebrated news reporter and power lifter Gary Bobrovitz talks about his early diagnosis of prostate cancer at 49 years of age and how it impacted his life, reminding us that knowledge and action are the two most important things we can all use to combat the disease and live a long and healthy life.

Travel Insurance with Prostate Cancer

Pam Murray from AMA Travel gives a frank and knowledgeable discussion about traveling nationally and abroad and what you’re covered for, and what you’re not, when you’re getting insurance. She also talks about dealing with the complications of having prostate cancer, or other ailments, that could effect how you get coverage.